Viktor Zarev

Viktor Zarev

InvestorPlace Contributor

Expertise: Science, Technology, Defense, and Medicine Stock Review

Education: BS in Biology from Baylor University, MS in Computer Science from Pace University

Viktor Zarev is a Freelance Writer at InvestorPlace.com, where he aims to elucidate and simplify the world of high-tech stocks and cryptocurrencies. To accomplish this, Viktor specializes in distilling the most pertinent and critical details for investors to focus on.

He also writes in-depth research scripts for defense documentaries on YouTube as well as creative direction and copywriting for game studios. He is also a supply chain specialist in the defense industry.

Viktor holds a BS in Global Health Biology from Baylor University, where he graduated on the Medical Entomology Research Track, studying flaviviruses and developing vector control methods. He is currently earning an MS in Computer Science from Pace University, focusing on artificial intelligence and machine learning.

Recent Articles

Super Micro Computer Stock: Is SMCI a Buy After Losing 45% of Its Value in 5 Months?

By Viktor Zarev, InvestorPlace Contributor

Investors may want to take an honest look at the AI industry as a whole before buying into Super Micro Computer stock.

3 AI Stock Valuations That Can’t Keep Up With Reality

By Viktor Zarev, InvestorPlace Contributor

Investors would be wise to keep an eye on these three overvalued AI stocks before deciding to buy a position in them.

What Are the Hottest Biotech Stocks Right Now? 3 Top Picks.

By Viktor Zarev, InvestorPlace Contributor

Figuring out the hottest biotech stocks can be as simple as looking at the most traded stocks by volume in the last 24 hours.

3 EV Stocks to Sell Before JD Vance Tanks the Sector

By Viktor Zarev, InvestorPlace Contributor

Investors may want to keep an eye on these EV stocks to sell in the event of a Trump-Vance ticket victory in November.

Intel Stock Analysis: Hold Off on INTC Until the Green Flags Fly Again

By Viktor Zarev, InvestorPlace Contributor

Investors should avoid buying into Intel stock until the company can find a way to fix these two big problems.

Load More